The study will assess the real life effectiveness of zoledronic acid in the management of
patients with osteoporosis over 4 years of treatment. Zoledronic acid will be compared to
oral bisphosphonates (OBP) with respect to the change in Bone Mineral Density (BMD) and
incidence of fractures.